Sandra Rembry

Sandra Rembry joined DNDi in June 2015 as a Senior Clinical Manager in the HAT team and took over the Clinical Project Leader role for the development of acoziborole in June 2021.

Sandra has more than 15 years of Clinical Project Management experience. She has been managing and coordinating multi-center international clinical projects in early and late phases (I/II/III) in different pharma companies and biotechnology (NovImmune, Merck Serono, Servier). Previously, she worked for 4 years at the hospital as a pharmacy resident. During that time, she developed strong skills to adapt to changes in various multicultural environments. She gained experience as a project leader, people mentoring and delivered projects across many disease areas, mainly neurology, psychiatry and infectious diseases.

Sandra holds a Pharmacy degree and a Master in Industrial and Biomedical Pharmacy from the University of Paris.